Dhanuka Agritech Limited — PPTs, 23-12-2024: Investor Presentation

Dhanuka Agritech has acquired international rights for the active ingredients Iprovalicarb and Triadimenol from Bayer AG, Germany, aiming to enhance its global presence in the ~$80 billion agrochemical market. This strategic move supports Dhanuka’s long-term vision to expand internationally and aligns with its recently established International Sales division. The acquisition strengthens Dhanuka's product portfolio and provides access to existing registrations, trademarks, and intellectual property in regions such as LATAM, MENA, Asia, and India, creating a steady stream of revenue. Bayer will assist Dhanuka during the transition, ensuring continuity in supply chains. The total consideration for this acquisition is approximately ₹167 Crore, with global revenue impacted by this move estimated at around ₹186 Crore for 2024. This acquisition presents a potential growth opportunity for the company as it shifts production to its own facilities, anticipating cost savings and enhanced optimization. Investors should monitor this development closely for its implications on revenue streams and market positioning.